| Literature DB >> 32665671 |
Sean W L Lipsit1,2, James Wilkinson3,4, Erin Scruten1, Antonio Facciuolo1, Connor Denomy1,2,5, Philip J Griebel1,6, Anthony Kusalik5, Graham Plastow3, Scott Napper7,8.
Abstract
Inter-individual variance in host immune responses following vaccination can result in failure to develop protective immunity leaving individuals at risk for infection in addition to compromising herd immunity. While developing more efficacious vaccines is one strategy to mitigate this problem, predicting vaccine responsiveness prior to vaccination could inform which individuals require adjunct disease management strategies. To identify biomarkers of vaccine responsiveness, a cohort of pigs (n = 120) were vaccinated and pigs representing the high (n = 6; 90th percentile) and low (n = 6; 10th percentile) responders based on vaccine-specific antibody responses following vaccination were further analyzed. Kinase-mediated phosphorylation events within peripheral blood mononuclear cells collected prior to vaccination identified 53 differentially phosphorylated peptides when comparing low responders with high responders. Functional enrichment analysis revealed pro-inflammatory cytokine signaling pathways as dysregulated, and this was further substantiated by detection of higher (p < 0.01) concentrations of interferon-gamma in plasma of low responders compared to high responders prior to vaccination. In addition, low responder pigs with high plasma interferon-gamma showed lower (p < 0.01) birth weights than high responder pigs. These associations between vaccine responsiveness, cytokine signaling within peripheral immune cells, and body weight in pigs provide both evidence and insight into potential biomarkers for identifying low responders to vaccination.Entities:
Mesh:
Substances:
Year: 2020 PMID: 32665671 PMCID: PMC7360594 DOI: 10.1038/s41598-020-68039-6
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Variability in vaccine responsiveness in a population of pigs vaccinated with RespiSure-One and selecting high and low responders. (A) Serum M. hyopneumoniae-specific IgG titer in vaccinated pigs. High responders (HR; green) and low responders (LR; red) were selected from the cohort. (B) Serum M. hyopneumoniae-specific IgG titer of HR and LR pigs 35 days following primary vaccination; lines represent the mean. n = 117 in (A) and n = 6 for both HR and LR groups in (B); ****p < 0.0001, unpaired two-tailed Student’s t-test.
Figure 2Differential phosphorylation patterns within PBMCs collected from high and low responder pigs prior to vaccination. (A) t-Distributed Stochastic Neighbor Embedding analysis and (B) Hierarchical clustering of high (HR) and low (LR) responders based on differential phosphorylation patterns in PBMCs collected prior to vaccination. (C) Top 10 most differentially phosphorylated peptides between HR (green) and LR (red) pigs prior to vaccination. n = 6 for both HR and LR groups.
Differentially phosphorylated peptides of PBMCs collected prior to vaccination between HR and LR pigs.
| Name | Target site | UniProt ID | FC | p-value |
|---|---|---|---|---|
| TRAF6 | Tyr353 | Q9Y4K3 | − 2.39 | 4.53E − 06 |
| Calmodulin | Tyr99 | P62158 | − 1.73 | 3.44E − 05 |
| gp130 | Ser782 | P40189 | 1.65 | 2.41E − 04 |
| BLNK | Tyr178 | Q8WV28 | 1.54 | 2.92E − 04 |
| NFAT2 | Ser172 | O95644 | 1.71 | 3.26E − 04 |
| Akt1 | Thr308 | P31749 | − 2.06 | 4.26E − 04 |
| Pyk2 | Ser399 | Q14289 | 1.99 | 4.72E − 04 |
| Mek1 | Ser217 | Q02750 | 1.68 | 5.27E − 04 |
| Rack1 | Tyr194 | P63244 | − 2.28 | 1.38E − 03 |
| Calmodulin | Thr79 | P62158 | 1.29 | 1.89E − 03 |
| MAVS | Ser233/234 | Q7Z434 | − 1.26 | 1.93E − 03 |
| PPP2Cα | Thr307 | P67775 | − 1.72 | 1.99E − 03 |
| Grb10 | Ser150 | Q13322 | 1.58 | 2.43E − 03 |
| Akt1 | Thr450 | P31749 | 1.37 | 2.71E − 03 |
| Syk | Tyr348 | P43405 | 1.40 | 4.15E − 03 |
| Kit | Tyr936 | P10721 | 1.49 | 4.61E − 03 |
| Caspase-8 | Tyr448 | Q14790 | 1.39 | 5.16E − 03 |
| PKACα | Thr197 | P17612 | − 2.10 | 5.43E − 03 |
| 4E-BP1 | Thr46 | Q13541 | 1.31 | 5.95E − 03 |
| TNIK | Thr181 | Q9UKE5 | 2.10 | 8.59E − 03 |
| p70S6K | Ser447 | P23443 | − 1.56 | 8.69E − 03 |
| Kit | Tyr568/570 | P10721 | 1.52 | 8.85E − 03 |
| IKK-α | Ser473 | O15111 | − 1.46 | 9.16E − 03 |
| p53 | Ser15 | P04637 | − 1.36 | 9.61E − 03 |
| Smad6 | Ser435 | O43541 | − 2.64 | 1.18E − 02 |
| PKCε | Thr566 | Q02156 | − 1.24 | 1.33E − 02 |
| Kit | Tyr721 | P10721 | 1.26 | 1.40E − 02 |
| IRAK1 | Thr100 | P51617 | − 1.44 | 1.42E − 02 |
| NFAT2 | Ser245 | O95644 | − 1.56 | 1.60E − 02 |
| Cofilin 1 | Ser2 | P23528 | 1.51 | 1.66E − 02 |
| HSP60 | Ser70 | P10809 | − 1.35 | 1.67E − 02 |
| PDGFRβ | Tyr740 | P09619 | 1.48 | 1.80E − 02 |
| Smad3 | Thr179 | P84022 | 1.30 | 1.81E − 02 |
| Lyn | Tyr396 | P07948 | 1.47 | 1.82E − 02 |
| TBK1 | Ser172 | Q9UHD2 | − 1.40 | 1.85E − 02 |
| JAK1 | Tyr220 | P23458 | − 2.91 | 1.95E − 02 |
| STAT6 | Tyr641 | P42226 | − 1.78 | 1.97E − 02 |
| HSP27 | Ser78 | P04792 | 1.92 | 2.07E − 02 |
| p300 | Ser2279 | Q09472 | − 1.27 | 2.12E − 02 |
| Cdc42 | Tyr32 | P60953 | − 1.48 | 2.28E − 02 |
| IKK-β | Tyr188 | O14920 | 1.30 | 2.63E − 02 |
| Smad1 | Ser214 | Q15797 | 1.41 | 2.96E − 02 |
| MSK2 | Ser360 | O75676 | − 1.43 | 3.24E − 02 |
| Bcl-2 | Ser87 | P10415 | − 1.27 | 3.66E − 02 |
| K8 | Tyr267 | P05787 | − 2.01 | 3.68E − 02 |
| CDK2 | Thr160 | P24941 | − 1.38 | 3.83E − 02 |
| fyn | Tyr531 | P06241 | 1.33 | 4.03E − 02 |
| CREB | Ser117 | P16220 | 1.27 | 4.11E − 02 |
| IKK-β | Tyr199 | O14920 | − 1.30 | 4.52E − 02 |
| ERK3 | Ser189 | Q16659 | − 1.86 | 4.66E − 02 |
| IKK-γ | Ser43 | Q9Y6K9 | − 1.33 | 4.73E − 02 |
| P27kip1 | Tyr74 | P46527 | − 1.55 | 4.90E − 02 |
| Sek1 | Ser80 | P45985 | − 1.28 | 4.94E − 02 |
Fold-change (FC) in HR relative to LR.
Pathway overrepresentation analysis of differentially phosphorylated peptides in PBMCs collected from HR and LR pigs prior to vaccination.
| Pathway name | Source name | Pathway p-value (corrected) | Number of uploaded genes for this entity | Number of genes in InnateDB for this entity |
|---|---|---|---|---|
| Innate Immune System | REACTOME | 4.11E − 20 | 27 | 563 |
| Signaling by Interleukins | REACTOME | 8.77E − 17 | 15 | 110 |
| RANKL | NETPATH | 1.22E − 16 | 14 | 84 |
| Immune System | REACTOME | 2.42E − 16 | 30 | 1,127 |
| BCR | NETPATH | 3.45E − 16 | 16 | 157 |
| Fc epsilon receptor (FCERI) signaling | REACTOME | 1.40E − 15 | 16 | 173 |
| JAK-STAT pathway and regulation | INOH | 2.04E − 15 | 18 | 273 |
| TNFalpha | NETPATH | 2.05E − 15 | 18 | 270 |
| VEGF signaling pathway | INOH | 2.08E − 15 | 16 | 183 |
| EPO signaling pathway | INOH | 2.18E − 15 | 16 | 181 |
| IL-7 signaling | INOH | 2.28E − 15 | 16 | 180 |
| Leptin | NETPATH | 7.64E − 15 | 13 | 96 |
| IL2 | NETPATH | 3.85E − 14 | 12 | 81 |
| IL3 | NETPATH | 5.66E − 14 | 12 | 84 |
| IL6 | NETPATH | 6.13E − 14 | 12 | 85 |
| Prostate cancer | KEGG | 1.18E − 13 | 12 | 90 |
| EGFR1 | NETPATH | 1.33E − 12 | 19 | 472 |
| BCR signaling pathway | PID NCI | 4.33E − 12 | 10 | 63 |
| MyD88-independent cascade | REACTOME | 8.80E − 12 | 11 | 97 |
| TRIF-mediated TLR3/TLR4 signaling | REACTOME | 8.80E − 12 | 11 | 97 |
| Toll Like Receptor 3 (TLR3) Cascade | REACTOME | 8.80E − 12 | 11 | 97 |
| Osteoclast differentiation | KEGG | 9.25E − 12 | 12 | 133 |
| Pathways in cancer | KEGG | 9.59E − 12 | 16 | 329 |
| Cytokine Signaling in Immune system | REACTOME | 9.60E − 12 | 15 | 267 |
| Signaling by NGF | REACTOME | 9.86E − 12 | 15 | 271 |
The top 25 pathways are presented.
Figure 3Elevated pro-inflammatory cytokines in low responder plasma compared to high responders prior to vaccination. Concentrations of (A) IFNγ, (B) TNFα, and (C) IL-1β within the plasma of high (HR) and low (LR) responder pigs collected prior to vaccination. (D) Correlation analysis of plasma IFNγ concentrations prior to vaccination and post-vaccination serum M. hyopneumoniae-specific IgG titer for HR (circles) and LR (triangles). Bars represent the mean. n = 6 for both HR and LR groups. Samples below the limit of lower quantification (LLOQ) were included as ½ the LLOQ for each assay. **p < 0.01, Mann–Whitney U-test.
Figure 4Vaccine-induced antibody responses correlate with both birth and weaning bodyweights of high and low responder pigs. (A) Bodyweight of high (HR; circles) and low (LR; squares) responder pigs at birth, weaning, and at the end of experiment. (B) Correlation analysis of birth weight and serum M. hyopneumoniae-specific IgG titer for HR (circles) and LR (squares) pigs. (C) Correlation analysis of birth weight and serum M. hyopneumoniae-specific IgG titer for the sample cohort. (D) Serum M. hyopneumoniae-specific IgG titer of pigs with median birth weight less than (circles) or greater than (squares) 1.4 kg, and pigs withs median wean weight less than (triangles) or greater than (diamonds) 6.8 kg. Data represents mean in (A) and mean ± SD in (D). Line represents best-fit line of linear regression in (B) and (D). n = 6 for both HR and LR groups in (A) and (B), n = 117 in (C), and n ≥ 57 for each group in (D). *p < 0.05, **p < 0.01, unpaired two-tailed Student’s t-test.
Figure 5Birth weight of high and low responder pigs correlate with both vaccine responsiveness and plasma IFNγ prior to vaccination. Correlation analysis of birth weight and both serum M. hyopneumoniae-specific IgG titer (black) and plasma IFNγ concentrations (red) prior to vaccination in high (HR) and (LR) responders. n = 6 for both HR and LR groups. A single data-point represents a single animal for each analysis. Samples below the limit of lower quantification (LLOQ) were plotted as ½ the LLOQ.